Authors: Adachi, JD Saag, KG Delmas, PD Liberman, UA Emkey, RD Seeman, E Lane, NE Kaufman, JM Poubelle, PEE Hawkins, F Correa-Rotter, R Menkes, CJ Rodriguez-Portales, JA Schnitzer, TJ Block, JA Wing, J McIlwain, HH Westhovens, R Brown, J Melo-Gomes, JA Gruber, BL Yanover, MJ Leite, MOR Siminoski, KG Nevitt, MC Sharp, JT Malice, MP Dumortier, T Czachur, M Carofano, W Daifotis, A

Citation: Jd. Adachi et al., Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids - A randomized, double-blind, placebo-controlled extension trial, ARTH RHEUM, 44(1), 2001, pp. 202-211

Authors: Chavassieux, PM Arlot, ME Roux, JP Portero, N Daifotis, A Yates, AJ Hamdy, NAT Malice, MP Freedholm, D Meunier, PJ

Citation: Pm. Chavassieux et al., Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies, J BONE MIN, 15(4), 2000, pp. 754-762

Authors: Bone, HG Adami, S Rizzoli, R Favus, M Ross, PD Santora, A Prahalada, S Daifotis, A Orloff, J Yates, J

Citation: Hg. Bone et al., Weekly administration of alendronate: Rationale and plan for clinical assessment, CLIN THER, 22(1), 2000, pp. 15-28

Authors: Orwoll, E Ettinger, M Weiss, S Miller, P Kendler, D Graham, J Adami, S Weber, K Lorenc, R Pietschmann, P Vandormael, K Lombardi, A Adachi, JD Bell, N Body, JJ Castro, A Daifotis, A Felsenberg, D Gilchrist, N Hoffman, A Maricic, M Rizzoli, R Silverman, S Valeriano, J

Citation: E. Orwoll et al., Alendronate for the treatment of osteoporosis in men, N ENG J MED, 343(9), 2000, pp. 604-610

Authors: Ravn, P Weiss, SR Rodriguez-Portales, JA McClung, MR Wasnich, RD Gilchrist, NL Sambrook, P Fogelman, I Krupa, D Yates, AJ Daifotis, A Fuleihan, GE

Citation: P. Ravn et al., Alendronate in early postmenopausal women: Effects on bone mass during long-term treatment and after withdrawal, J CLIN END, 85(4), 2000, pp. 1492-1497

Authors: Watts, N Freedholm, D Daifotis, A

Citation: N. Watts et al., The clinical tolerability profile of alendronate, INT J CL PR, 1999, pp. 51-61